| Literature DB >> 22312466 |
Mohammad Sazzad Khan1, Poonam Singh, Asim Azhar, Asma Naseem, Qudsia Rashid, Mohammad Anaul Kabir, Mohamad Aman Jairajpuri.
Abstract
The serpins (serine proteinase inhibitors) are structurally similar but functionally diverse proteins that fold into a conserved structure and employ a unique suicide substrate-like inhibitory mechanism. Serpins play absolutely critical role in the control of proteases involved in the inflammatory, complement, coagulation and fibrinolytic pathways and are associated with many conformational diseases. Serpin's native state is a metastable state which transforms to a more stable state during its inhibitory mechanism. Serpin in the native form is in the stressed (S) conformation that undergoes a transition to a relaxed (R) conformation for the protease inhibition. During this transition the region called as reactive center loop which interacts with target proteases, inserts itself into the center of β-sheet A to form an extra strand. Serpin is delicately balanced to perform its function with many critical residues involved in maintaining metastability. However due to its typical mechanism of inhibition, naturally occurring serpin variants produces conformational instability that allows insertion of RCL of one molecule into the β-sheet A of another to form a loop-sheet linkage leading to its polymerization and aggregation. Thus understanding the molecular basis and amino acid involved in serpin polymerization mechanism is critical to devising strategies for its cure.Entities:
Year: 2011 PMID: 22312466 PMCID: PMC3268027 DOI: 10.4061/2011/606797
Source DB: PubMed Journal: J Amino Acids ISSN: 2090-0112
Figure 1The scheme shown here (taking antithrombin as an example) represents the suicide substrate inhibition mechanism common to all inhibitory serpins. The scheme represents the interaction between the serpin (antithrombin, ATIII) and protease (E); ATIII-E is the noncovalent Michaelis complex; ATIII-E' is the proposed intermediate before partitioning; ATIII-E* is the stable protease-inhibitor complex; ATIII* is the cleaved ATIII. The outcome of the reaction is dependent on the partitioning between the inhibitory (k inh) and substrate pathways (k sub). The figures represent the cleaved and factor Xa bound ternary complexes of antithrombin [3].
Represents the Scissile bond in various serpins and their protease targets. Antithrombin is an efficient inhibitor of factor Xa, thrombin and factor IXa. Residues flanking the P1-P1′ are also critical for protease multispecificity.
|
|
Figure 2Important domains in serpin conformations. Several regions are important in controlling and modulating serpin conformational changes. The Reactive Centre Loop is involved in protease recognition and conformational transformation as strand 4A after inhibition. The P15–P9 portion of the RCL is called the hinge region. The point of initial insertion of the RCL which is the breach region, located at the top of the A β-sheet. Near the center of A β-sheet is the shutter domain. The breach and shutter are two major regions that assist sheet opening and accept the conserved hinge of the RCL when it inserts. The gate region is composed of s3C and s4C strands which has been primarily observed by studies of the transition latency. The image was drawn in chimera using the PDB file of native antitrypsin conformation.
Serpins and their known protease and nonprotease ligands.
| Serpin | Non protease ligands | Protease target |
|---|---|---|
| Antithrombin | Heparin, heparin sulfate | Thrombin, factor Xa, factor IXa |
| Antichymotrypsin | DNA, A | Cathepsin G |
| Alpha-1 Proteinase inhibitor | — | Neutrophil elastase |
| C1-Inhibitor | Heparin, collagen | Cls of complement system |
| Headpin | — | Lysosomal cathepsin |
| Heparin CofactorII | Heparin, dermatan sulfate | Thrombin |
| HSP47 | Collagen | — |
| Kallistatin | Heparin | Tissue Kallikerin |
| Maspin | Collagen | — |
| MENT | DNA | Nuclear cysteine proteinase |
| Plasminogen Activator inhibitor-1 | Heparin, heparin sulfate, vitronectin | tPA, uPA, thrombin, aPC |
| Protein C inhibitor | Heparin, retinoic acid | uPA, thrombin, aPC |
| Protease nexin-1 | Heparin, collagen | Thrombin uPA |
| Thyroxine Binding Globulin | Thyroxine, triiodothyronine | — |
| Protein Z dependent protease inhibitors (ZPI) | Protein Z | Factor Xa |
Figure 3Conformational changes in cofactor (heparin) bound serpin (antithrombin) and residues involved in cofactor interaction. Heparin binding produces a series of conformational changes in antithrombin; extension of helix D by forming a 2 turn helix (P-helix) at the N-terminal end and a 1.5 turn extension of D-helix towards the C-terminal end. Moving of strand 3A and strand 5A and expulsion of reactive center loop leads to activated antithrombin. Given below are the basic residues in the heparin binding site that interact with the pentasaccharide are Lys-11 and Arg-13 in the N-terminal end; Arg-46 and Arg-47 in the A-helix; and Lys-114, Phe-121, Phe-122, Lys-125, and Arg-129 in the region of the D-helix. The figures were made by using antithrombin PDB (native 1E05; activated 1E03) files and swiss-prot PDB viewer.
Unfavourable interactions that contribute to the metastability of the native antitrypsin. Nonideal interactions include the presence of hydrophobic pockets, overpacking of side-chains, the burial of polar groups, cavities in the hydrophobic core of the protein and polar nonpolar interactions [40]. Lys-335 is one of the residues in antitrypsin that has been shown to play a crucial role in conformational switch during the process of inhibition. Local strain due to Lys-335 interactions in the native state is critical for the inhibitory activity.
| Over packing of side chains | Polar-nonpolar interactions | Cavity filling mutations | Favourable interactions |
|---|---|---|---|
| Lys-335 | Phe-189—Gly-164 | Gly164Val | Native |
|
| |||
| Ile-169 | Thr-165-Val-161 | Ala183Val | Cleaved |
| Thr-165-Ile-169 | Lys-335 forms salt bridge with Asp-171 | ||
|
| |||
| Leu-172 | Leu-172-Asn-186 | Thr114Phe | Ile-169 |
| Lys-331-Val-333 | Gly117Phe | Lys-168-Glu-346 (salt bridge) | |
Figure 4Point mutation in representative serpins that leads to latency, dimerization, aggregation and polymerization. Figure shows different serpin members like antithrombin (1e05), α-1 antitrypsin (2qug), neuroserpin (1jjo), antichymotrypsin (4caa), heparin cofactor-II (1jmj) and C1-inhibitor along with corresponding natural variant that gives rise to polymerization. Images were prepared by using Pymol visualization tool.
Analysis of the residue burial and stability of natural variant of serpin involved in polymerization.
| Serpins | ASAb | ΔΔGc |
|---|---|---|
| (Native) | (kcal/mol) | |
| Antithrombin-P80 S/Ta | 0.0 | −0.97, −0.72 |
| Antithrombin-T85 M/Ka | 2.9 | −0.73, −3.04 |
| Antithrombin-C95R | 9.3 | −1.33 |
| Antithrombin-L99F | 1.1 | −1.03 |
| Antithrombin-N187D | 9.6 | −1.92 |
| Antithrombin-F229L | 1.5 | −0.92 |
| Antithrombin-A382T | 28.0 | −0.33 |
| Antithrombin-G424R | 2.5 | −1.30 |
| Antithrombin-P429L | 12.7 | −0.18 |
| Antitrypsin-F51L | 0.0 | −1.42 |
| Antitrypsin-S53F | 0.0 | −0.42 |
| Antitrypsin-V55P | 2.6 | −2.28 |
| Antitrypsin-E264V | 5.2 | 0.47 |
| Antitrypsin-E342T | 6.9 | 1.02 |
| Neuroserpin-S49P | 0.0 | −1.19 |
| Neuroserpin-S52R | 0.0 | −1.06 |
| Neuroserpin-H338R | 0.0 | −1.37 |
| Neuroserpin-G392E | 0.0 | −0.30 |
| Antichymotrypsin-L55P | 1.6 | −2.17 |
| Antichymotrypsin-P228A | 4.9 | −1.45 |
| Heparin Cofactor-II-E428K | 18.0 | −0.22 |
aTwo different variant at the same position.
bAccessible Surface Area (ASA) values were determined from DSSP algorithm. The pdb codes used for the analysis are as follows: antithrombin (1t1f), antitrypsin (1qlp), neuroserpin (1jjo and 3fgq), antichymotrypsin (1yxa), and heparin cofactor-II (1jmj).
cΔΔG were determined for the variants by using Imutant 2.0 at pH 7.0 and 25°C, the values were determined by using the difference of ΔG between the wild-type and the polymerization variants mentioned in the table.